Practice variations in indication, timing and outcome of Multiple Myeloma patients undergoing surgery for vertebral lesions – results from the European M2Spine study group - Quiz - MDSpire

Practice variations in indication, timing and outcome of Multiple Myeloma patients undergoing surgery for vertebral lesions – results from the European M2Spine study group

  • By

  • Vanessa Hubertus

  • Lennart Viezens

  • Martin Stangenberg

  • Anton M. Früh

  • Hanno S. Meyer

  • Raimunde Liang

  • Andreas Kramer

  • Christoph Orban

  • Johannes Kerschbaumer

  • Beate Kunze

  • Stefano Telera

  • Hannah Miller

  • Christian J. Entenmann

  • Emily J. von Bronewski

  • Charlotte Buhre

  • Leon-Gordian Leonhardt

  • Wolfgang Willenbacher

  • Irma Kvitsaridze

  • Dominik Laue

  • Matthias Pumberger

  • Theresa Keller

  • Güliz Acker

  • Jan Krönke

  • Igor-Wolfgang Blau

  • Ulrich Keller

  • Florian Ringel

  • Claudius Thomé

  • Bernhard Meyer

  • Peter Vajkoczy

  • Marc Dreimann

  • Julia Sophie Onken

  • June 13, 2025

  • 0 min

Share

Original Source(s)

Practice variations in indication, timing and outcome of Multiple Myeloma patients undergoing surgery for vertebral lesions – results from the European M2Spine study group

  • by Vanessa Hubertus, Lennart Viezens, Martin Stangenberg, Anton M. Früh, Hanno S. Meyer, Raimunde Liang, Andreas Kramer, Christoph Orban, Johannes Kerschbaumer, Beate Kunze, Stefano Telera, Hannah Miller, Christian J. Entenmann, Emily J. von Bronewski, Charlotte Buhre, Leon-Gordian Leonhardt, Wolfgang Willenbacher, Irma Kvitsaridze, Dominik Laue, Matthias Pumberger, Theresa Keller, Güliz Acker, Jan Krönke, Igor-Wolfgang Blau, Ulrich Keller, Florian Ringel, Claudius Thomé, Bernhard Meyer, Peter Vajkoczy, Marc Dreimann, Julia Sophie Onken

  • June 13, 2025

Related Content

Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myeloma

A propensity score matching study on clinical characteristics and risk factors of herpes zoster in malignant tumor

Treatment Intensity in the Frontline Setting for Transplant-Ineligible Patients With Multiple Myeloma

The management of newly diagnosed transplant-ineligible multiple myeloma remains challenging, in part due to the complexity of treatment decisions for frail patients. Recent subgroup analyses provide insight into whether quadruplet therapy may offer advantages over triplet therapy in this population.